SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-016511
Filing Date
2023-05-12
Accepted
2023-05-12 09:05:31
Documents
14
Period of Report
2023-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39482
2 ex99-1.htm EX-99.1 55087
3 ex99-1_001.jpg GRAPHIC 11659
  Complete submission text file 0001493152-23-016511.txt   293701

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20230512.xsd EX-101.SCH 3230
5 XBRL LABEL FILE pulm-20230512_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pulm-20230512_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3601
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 23913491
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences